Search filters

List of works by Lorenza Di Guardo

Bevacizumab plus fotemustine as first-line treatment in metastatic melanoma patients: clinical activity and modulation of angiogenesis and lymphangiogenesis factors.

scientific article published on 28 October 2010

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

scientific article

Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study

scientific article

Combined therapy with dabrafenib and trametinib in BRAF-mutated metastatic melanoma in a real-life setting: the INT Milan experience.

scientific article

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

scientific article

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme

scientific article published on 04 April 2014

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

scientific article

Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma

scientific article published on 25 September 2013

Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience

scientific article published on 01 November 2019

Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy

scientific article published on 11 March 2014

Outcome Evaluation of Patients with Limited Brain Metastasis From Malignant Melanoma, Treated with Surgery, Radiation Therapy, and Targeted Therapy

scientific article published on 31 May 2017

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

scientific article published on 14 December 2015

T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma

article

Vemurafenib in BRAFV600 mutated metastatic melanoma: a subanalysis of the Italian population of a global safety study.

scientific article published on January 2015

Paulina is supported by:

About Paulina

Help